Epirubicin Market Worth $243.99 Million, Globally, by 2028
The global epirubicin market research report provides deep dive regional and country level analysis of 18+ countries across 5 key regions, 30+ key company...
Source: globenewswire.com
Page 4 - Bone Sarcoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bone Sarcoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bone Sarcoma Today - Breaking & Trending Today
Doxorubicin Market Revenue to Cross $1,983.40 million by
Doxorubicin Market is expected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022. It is estimated to grow at a CAGR of 6.1% from 2022...
Source: globenewswire.com
High Risk for Persistent Opioid Use in Young People With Sarcoma
Roughly one quarter of adolescents and young adults with sarcoma will continue to use opioids after their cancer treatment, a new study shows.
Source: medscape.com
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases News provided by Share this article Share this article HOUSTON, Feb. 8, 2021 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the Agencja Badań Medycznych (The Medical Research Agency) a Polish state agency responsible for development of scientific research in the field of medi...
Source: prnewswire.com